Food and Drug Administration-approved endovascular repair devices for abdominal aortic aneurysms: a review.
Endovascular treatment of infrarenal abdominal aortic aneurysm (AAA) offers a less invasive alternative to conventional open repair. Currently, only four devices are Food and Drug Administration (FDA)-approved for use in endovascular aneurysm repair (EVAR) of AAA in the United States. All four devices are associated with a high technical success rate and less morbidity than open surgical repair. Each device has its inherent design advantages and disadvantages that must be matched with patient and AAA characteristics. This review will discuss and compare the technology and procedural outcomes data of the current FDA-approved EVAR devices.
Tan
Jack Wei Chieh
JW
Division of Cardiovascular Medicine, University of California Davis Medical Center, 4860 Y Street, Sacramento, CA 95817, USA.
Yeo
Khung Keong
KK
Laird
John R
JR
D017544:Aortic Aneurysm, Abdominal / Q000628:therapy*; D001807:Blood Vessel Prosthesis; D019917:Blood Vessel Prosthesis Implantation / Q000295:instrumentation*; D002986:Clinical Trials as Topic; D018795:Device Approval; D006801:Humans; D017063:Outcome Assessment, Health Care; D018579:Patient Selection; D011474:Prosthesis Design; D014481:United States; D014486:United States Food and Drug Administration